JP2023169297A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023169297A5 JP2023169297A5 JP2023150185A JP2023150185A JP2023169297A5 JP 2023169297 A5 JP2023169297 A5 JP 2023169297A5 JP 2023150185 A JP2023150185 A JP 2023150185A JP 2023150185 A JP2023150185 A JP 2023150185A JP 2023169297 A5 JP2023169297 A5 JP 2023169297A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- subject
- antibody
- chronic kidney
- kidney disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025089860A JP2025128207A (ja) | 2015-07-31 | 2025-05-29 | ヘプシジン媒介性障害を治療するための方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562199434P | 2015-07-31 | 2015-07-31 | |
| US62/199,434 | 2015-07-31 | ||
| US201562268788P | 2015-12-17 | 2015-12-17 | |
| US62/268,788 | 2015-12-17 | ||
| JP2018525517A JP2018529756A (ja) | 2015-07-31 | 2016-07-28 | ヘプシジン媒介性障害を治療するための方法 |
| PCT/US2016/044528 WO2017023699A1 (en) | 2015-07-31 | 2016-07-28 | Methods for treating hepcidin-mediated disorders |
| JP2021198768A JP7386838B2 (ja) | 2015-07-31 | 2021-12-07 | ヘプシジン媒介性障害を治療するための方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021198768A Division JP7386838B2 (ja) | 2015-07-31 | 2021-12-07 | ヘプシジン媒介性障害を治療するための方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025089860A Division JP2025128207A (ja) | 2015-07-31 | 2025-05-29 | ヘプシジン媒介性障害を治療するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023169297A JP2023169297A (ja) | 2023-11-29 |
| JP2023169297A5 true JP2023169297A5 (https=) | 2024-05-14 |
| JP7691464B2 JP7691464B2 (ja) | 2025-06-11 |
Family
ID=57886392
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018525517A Pending JP2018529756A (ja) | 2015-07-31 | 2016-07-28 | ヘプシジン媒介性障害を治療するための方法 |
| JP2021198768A Active JP7386838B2 (ja) | 2015-07-31 | 2021-12-07 | ヘプシジン媒介性障害を治療するための方法 |
| JP2023150185A Active JP7691464B2 (ja) | 2015-07-31 | 2023-09-15 | ヘプシジン媒介性障害を治療するための方法 |
| JP2025089860A Pending JP2025128207A (ja) | 2015-07-31 | 2025-05-29 | ヘプシジン媒介性障害を治療するための方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018525517A Pending JP2018529756A (ja) | 2015-07-31 | 2016-07-28 | ヘプシジン媒介性障害を治療するための方法 |
| JP2021198768A Active JP7386838B2 (ja) | 2015-07-31 | 2021-12-07 | ヘプシジン媒介性障害を治療するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025089860A Pending JP2025128207A (ja) | 2015-07-31 | 2025-05-29 | ヘプシジン媒介性障害を治療するための方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US20170029499A1 (https=) |
| EP (2) | EP3888752A1 (https=) |
| JP (4) | JP2018529756A (https=) |
| KR (2) | KR102889430B1 (https=) |
| CN (3) | CN108026582A (https=) |
| AU (2) | AU2016302768B2 (https=) |
| BR (1) | BR112018001853A2 (https=) |
| CA (2) | CA2991637C (https=) |
| EA (1) | EA201890185A1 (https=) |
| ES (1) | ES2877708T3 (https=) |
| IL (2) | IL256615B (https=) |
| MX (1) | MX2018000778A (https=) |
| NZ (1) | NZ739392A (https=) |
| SG (1) | SG10201913062SA (https=) |
| TW (3) | TW202043482A (https=) |
| WO (1) | WO2017023699A1 (https=) |
| ZA (1) | ZA202003889B (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2991637C (en) * | 2015-07-31 | 2022-07-05 | Medimmune Limited | Methods for treating hepcidin-mediated disorders |
| KR20200012823A (ko) | 2017-02-01 | 2020-02-05 | 예일 유니버시티 | 이뇨제 내성의 치료 |
| WO2018225063A1 (en) * | 2017-06-04 | 2018-12-13 | Rappaport Family Institute For Research In The Medical Sciences | Method of predicting personalized response to cancer treatment with immune checkpoint inhibitors and kits therefor |
| EP3735421A4 (en) | 2018-01-05 | 2021-09-22 | Corvidia Therapeutics, Inc. | METHOD OF TREATMENT OF IL-6 MEDIATED INFLAMMATION WITHOUT IMMUNSUPPRESSION |
| CN111217819B (zh) * | 2018-11-27 | 2021-05-14 | 杭州科巢生物科技有限公司 | 乌帕替尼的合成方法 |
| JP7701273B2 (ja) | 2019-05-01 | 2025-07-01 | ノヴォ ノルディスク アー／エス | 抗ｉｌ－６抗体製剤 |
| CN114375205A (zh) * | 2019-06-20 | 2022-04-19 | 武田药品工业株式会社 | 用基于病毒的基因疗法进行治疗的方法 |
| US20220372135A1 (en) | 2019-09-27 | 2022-11-24 | Disc Medicine, Inc. | Methods for treating myelofibrosis and related conditions |
| KR20220107252A (ko) | 2019-11-29 | 2022-08-02 | 키맵 리미티드 | 생리학적 철분 과다에 대한 치료 |
| CN115243762A (zh) * | 2020-04-07 | 2022-10-25 | 迈威(美国)生物治疗有限公司 | 抗tmprss6抗体及其用途 |
| EP4142721A1 (en) * | 2020-04-29 | 2023-03-08 | Bioage Labs, Inc. | Hypoxia-inducible factor prolyl hydroxylase inhibitors for treating aging-related conditions |
| KR20230012539A (ko) | 2020-05-13 | 2023-01-26 | 디스크 메디슨, 인크. | 골수섬유증을 치료하기 위한 항-헤모주벨린 (hjv) 항체 |
| AR122933A1 (es) | 2020-07-10 | 2022-10-19 | Novo Nordisk As | Métodos para tratar la enfermedad cardiovascular |
| TWI907583B (zh) * | 2020-12-11 | 2025-12-11 | 大陸商江蘇恒瑞醫藥股份有限公司 | Jak抑制劑在腎臟疾病中的應用 |
| WO2022240877A1 (en) | 2021-05-11 | 2022-11-17 | Regeneron Pharmaceuticals, Inc. | Anti-tmprss6 antibodies and uses thereof |
| CN113502325B (zh) * | 2021-07-02 | 2024-09-10 | 厦门市妇幼保健院(厦门市优生优育服务中心、厦门大学附属妇女儿童医院、厦门市林巧稚妇女儿童医院) | 用于孕期铁营养缺乏风险评估检测试剂盒与应用方法 |
| JP2024540480A (ja) | 2021-11-17 | 2024-10-31 | ディスク・メディシン・インコーポレイテッド | 腎臓疾患の貧血を処置する方法 |
| AU2023283829A1 (en) * | 2022-06-09 | 2024-11-07 | Disc Medicine, Inc. | Methods for treating blood loss conditions |
| EP4615867A1 (en) * | 2022-11-11 | 2025-09-17 | Tourmaline Bio, Inc. | Methods for the treatment of cardiovascular disease |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6808194A (en) | 1993-05-31 | 1994-12-20 | Chugai Seiyaku Kabushiki Kaisha | Reconstructed human antibody against human interleukin-6 |
| US7083784B2 (en) | 2000-12-12 | 2006-08-01 | Medimmune, Inc. | Molecules with extended half-lives, compositions and uses thereof |
| PT2308888T (pt) | 2001-11-14 | 2017-05-03 | Janssen Biotech Inc | Anticorpos anti-il-6, composições, métodos e utilizações |
| US20060078533A1 (en) * | 2004-10-12 | 2006-04-13 | Omoigui Osemwota S | Method of prevention and treatment of aging and age-related disorders including atherosclerosis, peripheral vascular disease, coronary artery disease, osteoporosis, arthritis, type 2 diabetes, dementia, alzheimer's disease and cancer |
| US20060078532A1 (en) * | 2004-10-12 | 2006-04-13 | Omoigui Osemwota S | Method of prevention and treatment of Atherosclerosis, Peripheral vascular disease, Coronary artery disease, aging and age-related disorders including osteoporosis, arthritis, type 2 diabetes, dementia and Alzheimer's disease |
| US20060275294A1 (en) * | 2002-08-22 | 2006-12-07 | Omoigui Osemwota S | Method of prevention and treatment of aging, age-related disorders and/or age-related manifestations including atherosclerosis, peripheral vascular disease, coronary artery disease, osteoporosis, arthritis, type 2 diabetes, dementia, alzheimers disease and cancer |
| US7482436B2 (en) | 2002-08-30 | 2009-01-27 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Human antihuman interleukin-6 antibody and fragment of antibody |
| JP4960096B2 (ja) * | 2003-09-22 | 2012-06-27 | ペントラコール ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｉｌ−６の生物学的効果を減じる化合物の使用 |
| ATE464908T1 (de) | 2004-02-11 | 2010-05-15 | Warner Lambert Co | Verfahren zur behandlung von osteoarthritis mit anti-il-6 antikörpern |
| JP2008529968A (ja) * | 2005-02-08 | 2008-08-07 | 国立循環器病センター総長 | インスリン様成長因子−１（ｉｇｆ−１）を使用する慢性重症心不全を処置するための新規方法 |
| JO3058B1 (ar) | 2005-04-29 | 2017-03-15 | Applied Molecular Evolution Inc | الاجسام المضادة لمضادات -اي ال-6,تركيباتها طرقها واستعمالاتها |
| ES2694247T3 (es) | 2005-05-20 | 2018-12-19 | Ablynx N.V. | NanobodiesTM mejorados para el tratamiento de trastornos mediados por agregación |
| US7820790B2 (en) * | 2005-07-13 | 2010-10-26 | Amgen Mountain View Inc. | IL-6 binding proteins |
| AR058135A1 (es) * | 2005-10-21 | 2008-01-23 | Chugai Pharmaceutical Co Ltd | Agentes para el tratamiento de cardiopatias |
| CN101563365B (zh) | 2006-08-03 | 2012-10-31 | 瓦西尼斯公司 | 抗-il-6单克隆抗体及其用途 |
| TW200831528A (en) * | 2006-11-30 | 2008-08-01 | Astrazeneca Ab | Compounds |
| TW201307390A (zh) * | 2007-02-02 | 2013-02-16 | Amgen Inc | 海帕西啶（ｈｅｐｃｉｄｉｎ）、海帕西啶拮抗劑及使用方法 |
| US8062864B2 (en) | 2007-05-21 | 2011-11-22 | Alderbio Holdings Llc | Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies |
| US8404235B2 (en) | 2007-05-21 | 2013-03-26 | Alderbio Holdings Llc | Antagonists of IL-6 to raise albumin and/or lower CRP |
| US9884899B2 (en) * | 2007-07-06 | 2018-02-06 | Promedior, Inc. | Methods for treating fibrosis using CRP antagonists |
| MX2010012031A (es) | 2008-05-13 | 2011-01-20 | Novimmune Sa | Anticuerpos anti-il-6/il-6r y metodos de uso de los mismos. |
| US8188235B2 (en) | 2008-06-18 | 2012-05-29 | Pfizer Inc. | Antibodies to IL-6 and their uses |
| US8323649B2 (en) | 2008-11-25 | 2012-12-04 | Alderbio Holdings Llc | Antibodies to IL-6 and use thereof |
| KR20110112307A (ko) * | 2008-11-25 | 2011-10-12 | 앨더 바이오파마슈티컬즈, 인코포레이티드 | 알부민을 상승시키고 및／또는 ｃｒｐ를 낮추는 ｉｌ６의 길항제 |
| CN104119438A (zh) | 2009-01-29 | 2014-10-29 | 米迪缪尼有限公司 | 延长体内半衰期的人抗il-6抗体及其在治疗肿瘤、自身免疫性疾病和炎症性疾病中的应用 |
| KR101913109B1 (ko) * | 2009-03-18 | 2018-10-31 | 리스버로직스 코퍼레이션 | 신규한 소염제 |
| CN102740888B (zh) * | 2009-11-24 | 2016-10-12 | 奥尔德生物制药公司 | Il-6抗体及其用途 |
| MX342810B (es) | 2011-03-03 | 2016-10-13 | Apexigen Inc | Anticuerpos del receptor anti-interleucina-6 (anti-il-6) y sus metodos de uso. |
| FR2978964B1 (fr) * | 2011-08-09 | 2015-02-20 | Conservatoire Nat Arts | Composition vaccinale anti-il-6 |
| WO2013175276A1 (en) | 2012-05-23 | 2013-11-28 | Argen-X B.V | Il-6 binding molecules |
| CN104768578A (zh) * | 2012-10-25 | 2015-07-08 | 米迪缪尼有限公司 | 稳定的低粘度抗体配制品 |
| CN104903349B (zh) | 2012-11-08 | 2018-10-19 | 十一生物治疗股份有限公司 | Il-6拮抗剂及其应用 |
| MX373894B (es) * | 2012-11-08 | 2020-07-09 | Clearside Biomedical Inc | Métodos y dispositivos para el tratamiento de trastornos oculares en sujetos humanos. |
| WO2014152006A2 (en) | 2013-03-15 | 2014-09-25 | Intrinsic Lifesciences, Llc | Anti-hepcidin antibodies and uses thereof |
| US20160130340A1 (en) | 2013-10-07 | 2016-05-12 | Alderbio Holdings Llc | Dosing regimens using anti-il-6 antibodies for the treatment of rheumatoid and psoriatic arthritis |
| US9139648B1 (en) * | 2014-07-15 | 2015-09-22 | Kymab Limited | Precision medicine by targeting human NAV1.9 variants for treatment of pain |
| UY36449A (es) | 2014-12-19 | 2016-07-29 | Novartis Ag | Composiciones y métodos para anticuerpos dirigidos a bmp6 |
| CA2991637C (en) * | 2015-07-31 | 2022-07-05 | Medimmune Limited | Methods for treating hepcidin-mediated disorders |
| KR20200012823A (ko) | 2017-02-01 | 2020-02-05 | 예일 유니버시티 | 이뇨제 내성의 치료 |
-
2016
- 2016-07-28 CA CA2991637A patent/CA2991637C/en active Active
- 2016-07-28 JP JP2018525517A patent/JP2018529756A/ja active Pending
- 2016-07-28 CN CN201680045105.6A patent/CN108026582A/zh active Pending
- 2016-07-28 SG SG10201913062SA patent/SG10201913062SA/en unknown
- 2016-07-28 EP EP21157575.8A patent/EP3888752A1/en active Pending
- 2016-07-28 EA EA201890185A patent/EA201890185A1/ru unknown
- 2016-07-28 CN CN202511406827.7A patent/CN121243390A/zh active Pending
- 2016-07-28 KR KR1020247031313A patent/KR102889430B1/ko active Active
- 2016-07-28 NZ NZ73939216A patent/NZ739392A/en unknown
- 2016-07-28 CA CA3119498A patent/CA3119498A1/en active Pending
- 2016-07-28 BR BR112018001853A patent/BR112018001853A2/pt not_active Application Discontinuation
- 2016-07-28 WO PCT/US2016/044528 patent/WO2017023699A1/en not_active Ceased
- 2016-07-28 AU AU2016302768A patent/AU2016302768B2/en active Active
- 2016-07-28 EP EP16833574.3A patent/EP3329018B1/en not_active Revoked
- 2016-07-28 ES ES16833574T patent/ES2877708T3/es active Active
- 2016-07-28 MX MX2018000778A patent/MX2018000778A/es unknown
- 2016-07-28 US US15/222,507 patent/US20170029499A1/en not_active Abandoned
- 2016-07-28 KR KR1020187005991A patent/KR102709681B1/ko active Active
- 2016-07-28 CN CN202110454211.2A patent/CN113117074B/zh active Active
- 2016-07-29 TW TW109105227A patent/TW202043482A/zh unknown
- 2016-07-29 TW TW105124201A patent/TWI653339B/zh active
- 2016-07-29 TW TW107134726A patent/TWI778140B/zh active
-
2017
- 2017-12-27 IL IL256615A patent/IL256615B/en active IP Right Grant
-
2019
- 2019-11-19 AU AU2019268074A patent/AU2019268074B9/en active Active
-
2020
- 2020-06-26 ZA ZA2020/03889A patent/ZA202003889B/en unknown
- 2020-12-09 IL IL279308A patent/IL279308A/en unknown
-
2021
- 2021-03-09 US US17/195,757 patent/US20210292405A1/en not_active Abandoned
- 2021-12-07 JP JP2021198768A patent/JP7386838B2/ja active Active
-
2023
- 2023-09-15 JP JP2023150185A patent/JP7691464B2/ja active Active
-
2024
- 2024-12-23 US US18/999,882 patent/US20250129151A1/en active Pending
-
2025
- 2025-05-29 JP JP2025089860A patent/JP2025128207A/ja active Pending